• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种能在灵长类动物中诱导干扰素产生的改良聚肌苷酸-聚胞苷酸复合物。

A modified polyriboinosinic-polyribocytidylic acid complex that induces interferon in primates.

作者信息

Levy H B, Baer G, Baron S, Buckler C E, Gibbs C J, Iadarola M J, London W T, Rice J

出版信息

J Infect Dis. 1975 Oct;132(4):434-9. doi: 10.1093/infdis/132.4.434.

DOI:10.1093/infdis/132.4.434
PMID:810520
Abstract

A comlex of polyriboinosinic-polyribocytidylic acid (poly I-poly C) with poly-L-lysine and carboxymethylcellulose has been prepared. This complex is five to 10 times as resistant to hydrolysis by primate serum as the parent poly I-poly C. It has a thermal denaturation temperature about 40 C higher than that of poly I-poly C. The complex induces significant levels of serum interferon in monkeys and chimpanzees under conditions in which poly I-poly C itself induces no interferon.

摘要

已制备出聚肌苷酸-聚胞苷酸(聚I-聚C)与聚-L-赖氨酸和羧甲基纤维素的复合物。该复合物对灵长类动物血清水解的抗性是母体聚I-聚C的5至10倍。其热变性温度比聚I-聚C高约40℃。在聚I-聚C本身不诱导干扰素的条件下,该复合物能在猴子和黑猩猩中诱导出显著水平的血清干扰素。

相似文献

1
A modified polyriboinosinic-polyribocytidylic acid complex that induces interferon in primates.一种能在灵长类动物中诱导干扰素产生的改良聚肌苷酸-聚胞苷酸复合物。
J Infect Dis. 1975 Oct;132(4):434-9. doi: 10.1093/infdis/132.4.434.
2
Interferon induction in primates by stabilized polyriboinosinic acid-polyribocytidylic acid: effect of component size.稳定化聚肌苷酸-聚胞苷酸在灵长类动物中诱导干扰素:组分大小的影响
Infect Immun. 1981 Nov;34(2):416-21. doi: 10.1128/iai.34.2.416-421.1981.
3
Interferon induction in cynomolgus and rhesus monkey after repeated doses of a modified polyriboinosinic-polyribocytidylic acid complex.重复给予改良聚肌苷酸-聚胞苷酸复合物后食蟹猴和恒河猴体内的干扰素诱导情况。
Antimicrob Agents Chemother. 1977 Jan;11(1):80-3. doi: 10.1128/AAC.11.1.80.
4
Polyriboinosinic-polyribocytidylic acid-poly-L-lysine complex [poly(ICL)] without carboxymethylcellulose (CMC): a new primate-effective interferon inducer.不含羧甲基纤维素(CMC)的聚肌苷酸-聚胞苷酸-聚-L-赖氨酸复合物[聚(ICL)]:一种新型的对灵长类有效的干扰素诱导剂。
Proc Soc Exp Biol Med. 1982 Feb;169(2):183-8. doi: 10.3181/00379727-169-41329.
5
Protective and toxic effects of a nuclease-resistant derivative of polyriboinosinic-polyribocytidylic acid on Venezuelan equine encephalomyelitis virus in rhesus monkeys.聚肌苷酸-聚胞苷酸的一种核酸酶抗性衍生物对恒河猴委内瑞拉马脑炎病毒的保护和毒性作用。
J Infect Dis. 1979 Mar;139(3):267-72. doi: 10.1093/infdis/139.3.267.
6
Historical overview of the use of polynucleotides in cancer.多核苷酸在癌症治疗中的应用历史概述。
J Biol Response Mod. 1985 Oct;4(5):475-80.
7
A comparison of interferon responses to poly ICLC in males and females.男性和女性对聚肌胞苷酸(poly ICLC)的干扰素反应比较。
J Interferon Res. 1992 May;Spec No:85-90. doi: 10.1089/jir.1992.1992.85.
8
Pharmacokinetics of interferon in blood, cerebrospinal fluid, and brain after administration of modified polyriboinosinic-polyribocytidylic acid and amphotericin B.给予修饰的聚肌苷酸-聚胞苷酸和两性霉素B后干扰素在血液、脑脊液及脑内的药代动力学
J Infect Dis. 1982 Dec;146(6):819-25. doi: 10.1093/infdis/146.6.819.
9
The kinetics of interferon induction by poly ICLC in humans.聚肌胞苷酸在人体内诱导干扰素的动力学。
J Interferon Res. 1988 Aug;8(4):419-25. doi: 10.1089/jir.1988.8.419.
10
A comparison of interferon responses to poly ICLC in males and females.男性和女性对聚肌胞苷酸(poly ICLC)的干扰素反应比较。
J Interferon Res. 1985 Summer;5(3):423-8. doi: 10.1089/jir.1985.5.423.

引用本文的文献

1
Shared neoantigens for cancer immunotherapy.用于癌症免疫治疗的共享新抗原。
Mol Ther Oncol. 2025 Mar 28;33(2):200978. doi: 10.1016/j.omton.2025.200978. eCollection 2025 Jun 18.
2
Toll-like receptor agonists as cancer vaccine adjuvants. toll 样受体激动剂作为癌症疫苗佐剂。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2297453. doi: 10.1080/21645515.2023.2297453. Epub 2023 Dec 28.
3
Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy. Toll 样受体 (TLRs) 及其激动剂在癌症疫苗和免疫治疗中的应用。
Front Immunol. 2023 Oct 23;14:1227833. doi: 10.3389/fimmu.2023.1227833. eCollection 2023.
4
Innate and Adaptive Responses of Intratumoral Immunotherapy with Endosomal Toll-Like Receptor Agonists.内体 Toll 样受体激动剂肿瘤内免疫疗法的固有和适应性反应
Biomedicines. 2022 Jul 4;10(7):1590. doi: 10.3390/biomedicines10071590.
5
An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives.疫苗佐剂概述:当前证据与未来展望
Vaccines (Basel). 2022 May 22;10(5):819. doi: 10.3390/vaccines10050819.
6
Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy.化学和生物分子策略在癌症免疫治疗中对 STING 通路的激活。
Chem Rev. 2022 Mar 23;122(6):5977-6039. doi: 10.1021/acs.chemrev.1c00750. Epub 2022 Feb 2.
7
Adjuvants: Engineering Protective Immune Responses in Human and Veterinary Vaccines.佐剂:在人用和兽用疫苗中设计保护性免疫应答。
Methods Mol Biol. 2022;2412:179-231. doi: 10.1007/978-1-0716-1892-9_9.
8
The Sympathetic Nervous System Modulates Cancer Vaccine Activity through Monocyte-Derived Cells.交感神经系统通过单核细胞衍生细胞调节癌症疫苗的活性。
J Immunol. 2021 Dec 15;207(12):3131-3140. doi: 10.4049/jimmunol.2100719. Epub 2021 Nov 12.
9
Exploration of Pattern Recognition Receptor Agonists as Candidate Adjuvants.探索模式识别受体激动剂作为候选佐剂。
Front Cell Infect Microbiol. 2021 Oct 6;11:745016. doi: 10.3389/fcimb.2021.745016. eCollection 2021.
10
Advancing Autism Research From Mice to Marmosets: Behavioral Development of Offspring Following Prenatal Maternal Immune Activation.推进自闭症研究:从老鼠到狨猴——产前母体免疫激活后后代的行为发育
Front Psychiatry. 2021 Aug 6;12:705554. doi: 10.3389/fpsyt.2021.705554. eCollection 2021.